Clinical Trials Logo

Colorectal Cancer Stage IV clinical trials

View clinical trials related to Colorectal Cancer Stage IV.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03149679 Terminated - Clinical trials for Colorectal Cancer Metastatic

The p53 Colorectal Cancer Trial

Start date: May 9, 2017
Phase: Phase 2
Study type: Interventional

Single center, open labeled, phase 2 clinical trial, where patients with metastatic colorectal cancer are selected for treatment with dose dense Cyclophosphamide every second week based on TP53 mutation status; i.e. only patients with TP53 mutated tumors may be included in the treatment arm.